OGI, one of six genome centres across Canada, is part of the new MaRS Discovery District, serving the innovation pipeline in Ontario. Working with Genome Canada, Ontario’s Ministry of Research and Innovation (MRI), and other private and public sector partners, OGI currently oversees a $500 million portfolio of 33 leading-edge genomics and proteomics research projects as well as a world-class technology platform at The Centre for Applied Genomics (TCAG) based in Toronto.
Ontario-led international projects, an important part of OGI’s portfolio, are underway through: the Structural Genomics Consortium (SGC), a shared research initiative at the Universities of Oxford, Toronto and the Karolinska Institute in Stockholm, Sweden; and the International Regulome Consortium (IRC), which includes scientists from Australia, Britain, Canada, France, the Netherlands, Singapore, and the U.S.; and a Genome Canada-Genoma España initiative.
OGI's three major roles are:
- Attracting investment for internationally recognized genomics-based or genomics-derived research that is of strategic importance to Ontario and all of the world,
- Accelerating the impact of genomics resources created through research to increase business development in Ontario, in Canada, and internationally,
- Increasing public awareness of genomics and its impact on society through education, dialogue on social and ethical issues, and public outreach programs.
Ontario Genomics Institute
MaRS Centre, Heritage Building
101 College Street, Suite HL50
Toronto, ON
CANADA M5G 1L7
Phone: 416-977-9582
Fax: 416-977-8342
E-mail: info@ontariogenomics.caPresident and ceo. 2008
Christian Burks, PhD
President & CEO
Ontario Genomics Institute
cburks@OntarioGenomics.ca
416-673-6598
댓글 0